What Is a Kenalog Injection? Uses and Side Effects

A Kenalog injection delivers triamcinolone acetonide, a synthetic corticosteroid, directly into a joint, a skin lesion, a muscle, or other tissue to suppress inflammation at the source. It is one of the most widely used injectable steroids in medicine, prescribed for conditions ranging from arthritis and allergies to keloid scars and eye disease. The drug’s appeal comes from its unusually long-lasting effect compared to many other steroids, but that same persistence also means side effects can linger. Understanding where Kenalog fits and where it doesn’t helps you have a much more informed conversation with your doctor before rolling up your sleeve.

What Makes Kenalog Different From Other Steroids

Triamcinolone acetonide, the active ingredient in Kenalog, belongs to the glucocorticoid family. What sets it apart is its physical behavior once injected. The drug has very low solubility in blood, which means it doesn’t dissolve and leave the injection site quickly. Instead, it forms a depot of tiny crystals that release the steroid slowly over days to weeks. Researchers have attributed this prolonged effect to a combination of factors: the acetonide ester structure makes the molecule resist dissolving, it absorbs slowly from the injection site, and the kidneys clear it at a low rate.¹ This slow-release behavior is why a single Kenalog shot can keep working for weeks, whereas some other injectable steroids wear off in days.

That crystal structure, though, is a double-edged sword. The particles in Kenalog-40 (the standard formulation) are significantly larger than those in Triesence, a preservative-free version designed for injection into the eye.² Particle size matters because larger crystals can provoke more local irritation, which is one reason why not every triamcinolone product is interchangeable.

Joint Pain and Arthritis

The most common reason people encounter Kenalog is joint injection for osteoarthritis, especially in the knee. Your doctor injects the steroid directly into the joint space, where it reduces the inflammation that drives pain and stiffness. Relief typically begins within a day or two and can last several weeks to a few months.

A multicenter trial comparing a low dose (10 mg) to the standard dose (40 mg) in knee osteoarthritis found that both doses produced significant pain improvement at 4 and 12 weeks. The low dose was statistically non-inferior to the high dose, meaning it performed about as well.³ This is useful information if you’re concerned about side effects from higher doses, because it suggests your doctor may have room to use less steroid and still get a good result.

One head-to-head comparison with methylprednisolone, another common injectable steroid, found no significant difference in pain scores across 24 weeks of follow-up when the two drugs were injected into opposite knees of the same patients.⁴ However, a broader systematic review looking across multiple corticosteroids found that triamcinolone hexacetonide, a close chemical relative, often produced faster pain relief than triamcinolone acetonide and had better long-term response rates in joint arthritis.⁵ The practical takeaway is that Kenalog works well for joints, but your physician’s choice of steroid may depend on the specific joint, the condition being treated, and their clinical experience.

Skin Conditions and Scars

Dermatologists have used Kenalog for decades, injecting it directly into keloid scars, hypertrophic scars, and stubborn cystic acne. For keloids, intralesional injection flattens the raised scar tissue and relieves the itching that often accompanies these lesions. A prospective trial found that the majority of keloids flattened completely after a course of Kenalog injections, with itching also stopping. The catch was durability: about a third of patients saw partial recurrence within a year, and the recurrence rate climbed to roughly half at five years. Combining injection with surgical removal of the keloid did not improve those results over injection alone.⁶

For cystic acne, a diluted Kenalog injection into an individual nodule can shrink the lesion within a day or two, which is why it’s sometimes called a “cortisone shot” in dermatology offices. Research has found significant reductions in lesion size and severity from intralesional steroid injections, and the localized delivery keeps systemic exposure low compared to oral steroids. If you’re getting one of these for an angry cyst before a big event, ask your dermatologist about the concentration they’re using; lower dilutions reduce the risk of a telltale dent forming in the skin afterward.

Triamcinolone acetonide also appears in systematic reviews of intralesional treatments for hypertrophic scars. One review covering multiple delivery methods found favorable efficacy and safety for triamcinolone when injected into scars, including when combined with 5-fluorouracil for hypertrophic scarring.⁷

Seasonal Allergies

Some doctors give a single intramuscular Kenalog injection for severe seasonal allergic rhinitis when other treatments haven’t worked. This use is more controversial than joint or skin injections because it delivers a systemic dose of steroid, meaning the drug circulates throughout your body rather than staying local. A randomized trial comparing intramuscular triamcinolone acetonide to placebo for seasonal allergies found that 94% of the treatment group improved or had symptoms resolve within 10 days, compared to only 10% of the placebo group.⁸ The effect is dramatic, which is why some patients seek it out every spring.

The trade-off is that a single intramuscular shot can suppress your body’s natural cortisol production for weeks, and the systemic exposure raises all the usual corticosteroid risks: blood sugar disruption, mood changes, bone thinning with repeated use, and immune suppression. Most allergy guidelines now recommend nasal steroid sprays, antihistamines, and immunotherapy before resorting to systemic injections. If your doctor proposes this route, it’s worth asking whether you’ve genuinely exhausted the alternatives.

Eye Conditions

Triamcinolone acetonide has carved out an important niche in ophthalmology, though the formulation matters a great deal here. Intravitreal injection, where a small amount of the drug is placed directly inside the eye, is used to treat macular edema from conditions like central retinal vein occlusion, diabetic eye disease, and age-related macular degeneration.⁹ It is also used in uveitis, a group of inflammatory eye diseases, where it can reduce the swelling in the retina that threatens vision.¹⁰

Case-control studies have shown efficacy in treating intraocular inflammation and macular edema from several autoimmune conditions, including Behçet’s disease and Vogt-Koyanagi-Harada syndrome.¹¹ Eye injections are typically handled by retinal specialists and carry their own set of risks, including elevated eye pressure and, rarely, infection inside the eye (endophthalmitis). The preservative-free formulation with smaller particles is usually preferred for intravitreal use to minimize inflammatory reactions.

Local Side Effects to Watch For

Because Kenalog is usually injected into a specific spot, the most common side effects are local. Skin changes at or near the injection site are the ones patients notice first. These include thinning of the skin (dermal atrophy), loss of fat under the skin (subcutaneous fat atrophy), and lightening of the skin color (hypopigmentation). In a prospective cohort study, subcutaneous fat atrophy occurred in about 7% of patients receiving extra-articular corticosteroid injections, all of them women. Hypopigmentation that developed 4 to 10 weeks after injection fully resolved on its own, though it took an average of about 7 months. Fat atrophy was less forgiving: two out of three cases showed only incomplete recovery.¹²

In rarer cases, the hypopigmentation and atrophy can follow the path of a lymphatic vessel away from the injection site, creating a branching pattern of lightened, thinned skin that extends beyond where the needle went in.¹³ This is cosmetically distressing but generally not dangerous. It’s more visible in people with darker skin tones, so if you have medium to dark skin and are getting a Kenalog injection in a visible area, this is something to discuss with your provider ahead of time.

Post-Injection Flare

A post-injection flare is a paradoxical burst of pain and swelling in the first hours to days after a joint injection. It happens because those slowly dissolving drug crystals temporarily irritate the joint lining, triggering an inflammatory reaction that feels like the original problem just got worse. Most flares are mild and self-limiting, resolving with ice and over-the-counter pain relievers.

Severe flares are uncommon but dramatic. One documented case involved a 56-year-old woman who developed such intense swelling and pain within two hours of a knee injection that she could not walk. The aspirated fluid contained triamcinolone crystals, confirming an acute crystal-induced inflammatory response rather than infection.¹⁴ This matters because the symptoms can look exactly like a joint infection (septic arthritis), which is a medical emergency. If you develop severe joint pain, redness, warmth, and fever after a Kenalog shot, get it checked promptly; ruling out infection is critical even though the most likely explanation is a flare.

Blood Sugar Effects for People With Diabetes

Corticosteroids raise blood glucose. This is true of Kenalog whether it is injected into a joint, under the skin, or into a muscle. For most people without diabetes, the bump is temporary and clinically insignificant. For people with type 2 diabetes, the spike can be substantial and comes on fast.

A study measuring blood glucose daily after steroid injections for musculoskeletal pain found that levels rose significantly on day one after the injection but returned to baseline by day two. The degree of the glucose spike was tied to how well-controlled the diabetes was beforehand: patients with a higher baseline HbA1c (above 7%) and those on insulin saw bigger jumps than patients with tighter control.¹⁵ The injection site and steroid dose did not significantly affect the glucose increase, suggesting this is a systemic effect of the drug getting into the bloodstream regardless of where it was delivered.

An extended-release formulation of triamcinolone acetonide (TA-ER) has been developed partly to address this problem. In a study of patients with knee osteoarthritis and type 2 diabetes, TA-ER caused smaller glucose spikes in the first three days compared to standard immediate-release Kenalog. The median rise in peak glucose was roughly half that of the standard formulation, and the time before glucose first reached a high threshold was dramatically longer.¹⁶ If you have diabetes and need a joint injection, ask your doctor whether this extended-release option is available and appropriate. Regardless of the formulation, you should monitor your blood sugar more frequently for at least a couple of days after the shot and have a plan to adjust insulin or medication if needed.

One small study specifically looking at triamcinolone acetonide injected behind the eye for diabetic eye disease found that long-term blood sugar control (HbA1c) and blood pressure were not significantly affected, though some patients still experienced short-term fasting glucose spikes.¹⁷

Infection Risk and Repeat Injection Safety

Any injection that breaks the skin carries some risk of introducing bacteria. With corticosteroid injections, the risk is compounded by the fact that the drug suppresses local immune defenses. An analysis of 278 complication cases reviewed by expert commissions found that treatment errors contributed in about 40% of cases. These errors included failure to maintain sterile technique, injecting when there was no clear indication, giving injections too close together in time, using excessive doses, and failing to recognize early signs of infection.¹⁸

Repeat injections into the same joint also raise concerns beyond infection. Over time, corticosteroids may accelerate cartilage loss and contribute to tendon weakening.¹⁹ This is why most orthopedic guidelines recommend limiting injections to three or four per joint per year, with a minimum interval of several weeks between them. The point isn’t that one shot is dangerous but that stacking them without adequate spacing shifts the risk-benefit balance.

What to Expect After the Injection

For joint injections in particular, rest in the immediate aftermath seems to matter. A review of post-injection recommendations for athletes concluded that one to two days of rest of the affected joint, followed by a gradual return to activity, helps maximize the benefit and reduce both cartilage stress and systemic absorption of the drug.²⁰ For intralesional skin injections, there is less formal guidance on activity restriction, though keeping the area clean and avoiding aggressive pressure on it for a day is common sense.

Mild soreness at the injection site for a day or two is normal. Ice can help. If the area becomes increasingly red, warm, and painful after the first 48 hours rather than improving, that pattern is more concerning for infection than for a typical post-injection flare and warrants a call to your doctor.

Kenalog and Breastfeeding

Nursing mothers sometimes hesitate about corticosteroid injections, worrying about drug transfer into breast milk. A case report that specifically measured triamcinolone levels in the milk of a breastfeeding patient who received therapeutic Kenalog injections into inflamed breast tissue found that the drug was undetectable in all milk samples. The patient was able to continue breastfeeding from the affected breast without interruption. While a single case report is not the same as a large study, the finding is reassuring and consistent with the drug’s low systemic bioavailability when injected locally. If you’re breastfeeding and offered a Kenalog injection for a joint or skin problem, this is something to weigh with your provider rather than automatically decline.